INVITAE CORP. news, videos and press releases - Page 2
For more news please use our advanced search feature.
INVITAE CORP. - More news...
INVITAE CORP. - More news...
- Invitae to Present at the William Blair 43rd Annual Growth Stock Conference
- New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology
- Invitae to Appeal Trial Verdict
- Invitae Reports First Quarter 2023 Financial Results
- Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023
- Invitae Publishes Annual Environmental, Social and Governance (ESG) Report
- New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung Cancer
- Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases
- Invitae Announces Partnership with Epic to Streamline Genetic Testing
- Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology
- Invitae to Present Data at The American Clinical Genetics Meeting 2023 That Supports Removing Barriers to Genetic Testing
- Invitae to Present at the TD Cowen 43rd Annual Health Care Conference
- Invitae Announces Convertible Notes and Share Exchange and New Convertible Notes Issuance
- Invitae Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Company Updates
- Invitae to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
- Invitae Appoints William H. Osborne to its Board of Directors
- Invitae Reports Preliminary 2022 Financial Results
- Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc.
- Invitae Executive Appointed to National Health Information Technology Advisory Committee
- Invitae Releases Data Use Transparency Report, Demonstrating the Impact of Patient Data on Genetic Research
- Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases
- Invitae Showcases Advances in Medical Genomics at the National Society of Genetic Counselors (NSGC) 41st Annual Conference
- Invitae Reports Third Quarter 2022 Financial Results
- Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy
- Invitae to Present Data at the American Society of Human Genetics Annual Meeting Furthering the Understanding of Variants of Uncertain Significance in Underrepresented Populations
- Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
- Invitae to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
- Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthcare
- Clinical Practice Guidelines Recommend Genetic Testing of All Patients with Breast Cancer
